Has David Michel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,931 in general payments to David Michel, MD across 62 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Michel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Michel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Michel, MD

Orthopaedic Surgery · Austin, TXNPI 1457779928

Payments from drug & device makers

$7,931in general payments, 2019–2025

Across 62 payments — averaging $127.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$7K
Davol Inc.$203
Welch Allyn$186
SPR Therapeutics, Inc$120
Solventum Corporation$100
Smith+Nephew$70

What the payments were for

Travel & lodging$3,20640%
Food & beverage$3,54045%
Education$1,00013%
Other$1862%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	55	$7,253
Davol Inc.	2	$203
Welch Allyn	1	$186
SPR Therapeutics, Inc	1	$120
Solventum Corporation	1	$100
Smith+Nephew	2	$70

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,931 in reported general payments places this provider in the 60th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$228,427

Medicare patients

333

Services billed

4,780

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XareltoRivaroxaban	24	$8,072
Celecoxib	167	$2,243
Oxycodone Hcl	282	$1,969
Ondansetron OdtOndansetron	166	$1,629
Cefadroxil	102	$844
Methylprednisolone	114	$677
Clindamycin Hcl	27	$237
Tramadol Hcl	56	$139
Gabapentin	19	$97
Amoxicillin	72	$58
Meloxicam	32	$53

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Austin

Robert GrahamAustin$6.3M
Robert JoseyAustin$1.9M
Eric HeinrichAustin$1.1M
David DodginAustin$770K
Stephen BurkhartSan Antonio$185.3M
Kirby HittTemple$9.1M
J Richard EvansonPlano$8.1M
Stefan KreuzerHouston$7M
Richard JonesDallas$6.3M
Howard HarrisBedford$4.6M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →